| |
|
|
|
Xtalks, online
2023 -10-05
Cell and gene therapy (CAGT) is a rapidly evolving field that holds enormous promise for ground-breaking treatments therapies in various diseases with unmet therapeutic needs. CAGT is poised to transform clinical development and medical care, and we here at Fortrea are thrilled to host this webinar to discuss recent innovations. This webinar will address recent progress in several therapeutic areas, then focus on updates in kidney disease and operational considerations when conducting cell and gene therapy studies.
Additionally, we will address several operational considerations that are critical in planning CAGT clinical development programs.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Jonathan Hogan, MD, Medical Director, Cabaletta Bio; Adjunct Associate Professor of Medicine, Division of Nephrology, University of Pennsylvania Barbara Gillespie, MD, MMS, FASN, VP and Therapeutic Head of Nephrology, Fortrea; Adjunct Professor, Division of Nephrology and Hypertension, University of North Carolina School of Medicine Frederick Derosier, DO, Vice President and General Manager, Rare Disease, Advanced Therapies and Pediatrics Team (RAPT), Clinical Lead, Enterprise Cell and Gene Therapy, Fortrea Paulla Dennis, Senior Director, Rare Disease, Advanced Therapies and Paediatrics Team (RAPT), Fortrea
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -10-05
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|